Treatment Strategies for Deficiency of Adenosine Deaminase 2.
Ombrello, Amanda K
Treatment Strategies for Deficiency of Adenosine Deaminase 2. [electronic resource] - The New England journal of medicine 04 2019 - 1582-1584 p. digital
Publication Type: Letter
1533-4406
10.1056/NEJMc1801927 doi
Adalimumab--therapeutic use
Adenosine Deaminase--deficiency
Adolescent
Adult
Antibodies, Monoclonal--therapeutic use
Child
Child, Preschool
Drug Therapy, Combination
Etanercept--therapeutic use
Humans
Infliximab--therapeutic use
Intercellular Signaling Peptides and Proteins--deficiency
Metabolism, Inborn Errors--drug therapy
Plasma
Secondary Prevention
Stroke--prevention & control
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Young Adult
Treatment Strategies for Deficiency of Adenosine Deaminase 2. [electronic resource] - The New England journal of medicine 04 2019 - 1582-1584 p. digital
Publication Type: Letter
1533-4406
10.1056/NEJMc1801927 doi
Adalimumab--therapeutic use
Adenosine Deaminase--deficiency
Adolescent
Adult
Antibodies, Monoclonal--therapeutic use
Child
Child, Preschool
Drug Therapy, Combination
Etanercept--therapeutic use
Humans
Infliximab--therapeutic use
Intercellular Signaling Peptides and Proteins--deficiency
Metabolism, Inborn Errors--drug therapy
Plasma
Secondary Prevention
Stroke--prevention & control
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Young Adult